Neurological Games ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.0% 20.2% 13.9% 18.1% 13.4%  
Credit score (0-100)  11 5 15 7 16  
Credit rating  BB B BB B BB  
Credit limit (kDKK)  0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1

Net sales  0 0 0   0  
Gross profit  -1.0 -15.0 -11.2 -4.3 -3.5  
EBITDA  -1.0 -24.7 -11.2 -4.3 -3.5  
EBIT  -1.0 -24.7 -11.2 -4.3 -3.5  
Pre-tax profit (PTP)  -5.3 -33.3 -20.9 -7.2 -5.4  
Net earnings  -5.3 -33.3 -20.9 -7.2 -5.4  
Pre-tax profit without non-rec. items  -5.3 -33.3 -20.9 -7.2 -5.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  5.0 5.0 40.0 40.0 40.0  
Interest-bearing liabilities  40.0 50.0 28.7 30.7 32.5  
Balance sheet total (assets)  45.0 55.0 68.7 70.7 72.5  

Net Debt  25.9 42.1 -16.5 -11.1 -11.1  
 
See the entire balance sheet

Volume 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% -100.0%  
Gross profit  -1.0 -15.0 -11.2 -4.3 -3.5  
Gross profit growth  92.0% -1,335.9% 25.3% 61.8% 17.8%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  45 55 69 71 73  
Balance sheet change%  80.0% 22.2% 24.9% 2.9% 2.5%  
Added value  -1.0 -24.7 -11.2 -4.3 -3.5  
Added value %  0.0% 0.0% 0.0% -5,212.2% 0.0%  
Investments  -4 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 -1.0  
EBIT trend  -3.0 -4.0 -5.0 -5.0 -5.0  

Profitability 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1
EBITDA %  0.0% 0.0% 0.0% -5,212.2% 0.0%  
EBIT %  0.0% 0.0% 0.0% -5,212.2% 0.0%  
EBIT to gross profit (%)  100.0% 165.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% -8,784.1% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% -8,784.1% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% -8,784.1% 0.0%  
ROA %  -3.0% -49.5% -18.1% -6.1% -4.9%  
ROI %  -3.0% -49.5% -18.1% -6.1% -4.9%  
ROE %  -106.6% -666.3% -93.1% -18.0% -13.4%  

Solidity 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1
Equity ratio %  11.1% 9.1% 58.2% 56.6% 55.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 37,450.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% -13,506.1% 0.0%  
Net int. bear. debt to EBITDA, %  -2,484.5% -170.3% 147.6% 259.1% 315.3%  
Gearing %  800.0% 1,000.0% 71.8% 76.8% 81.3%  
Net interest  0 0 0 0 0  
Financing costs %  14.3% 19.1% 24.7% 9.9% 5.8%  

Liquidity 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  14.1 7.9 45.2 41.8 43.6  

Capital use efficiency 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 86,230.5% 0.0%  
Net working capital  40.0 50.0 28.7 30.7 32.5  
Net working capital %  0.0% 0.0% 0.0% 37,450.0% 0.0%  

Employee efficiency 
2019
2020/1
2020
2021/1
2021
2022/1
2022
2023/1
2023
2024/1
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0